J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 68,211 shares at $46.36 ($3.2M) on 2022-01-10, disclosed to the SEC on 2022-01-12.
Seasonal sale ($3.2M) by President and CEO — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.36 | 13,161 | $610K | 19.1% |
| 2 | $46.36 | 13,161 | $610K | 19.1% |
| 3 | $47.17 | 20,894 | $986K | 30.8% |
| 4 | $47.17 | 20,894 | $986K | 30.8% |
| 5 | $47.72 | 101 | $5K | 0.2% |
| Total | $46.86 avg | 68,211 |
| $3.2M |
| 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |